Element Biosciences Closes Acquisition Of Loop Genomics
02/08/22, 4:01 PM
Location
san diegoIndustry
genetics
life science
health care
biotechnology
agriculture and farming
science and engineering
biotechnology
health care
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced that the company has closed its acquisition of Loop Genomics, a long-read solutions company that enables short-read sequencers to obtain long range information. Loop Genomics’ Chief Executive Officer and Founder, Tuval Ben-Yehezkel, PhD, will join Element Biosciences’ leadership team as Senior Director, Applications.
Company Info
Location
San Diego, California, United States
Company info
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high-quality data, increase workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation, and biochemistry to drastically decrease run costs and capital costs while delivering high sequencing data quality.
Related People
New Feature: Generate AI-Powered Emails Instantly!
Use one of the following options:
- Click the AI button next to your contact's email to generate a draft automatically.
- Use Copy to Clipboard to paste the email into your favorite email service.
- Click Send via Webmail to use Gmail or another online client.
Important: If nothing happens when you click, you might not have a default email client set up.